Becton, Dickinson & Co. plans to close its Caesarea Medical Electronics, a producer of infusion pump systems, by June and ...

BD will close a facility in Caesarea, Israel, by the middle of the year. BD bought the site along with Caesarea Medical ...

Levodopa is most commonly administered orally, but this trial tested continuous, 24-hour levodopa delivery through a subcutaneous infusion pump. A total of 381 patients with Parkinson's disease in ...

Developed in 2010, the Regenstrief National Center for Medical Device Informatics (REMEDI) is a flagship software solution that collects infusion pump data from a broad range of manufacturers. REMEDI ...

a New Jersey-based medical device manufacturer known as BD, for repeatedly misleading investors about risks associated with its continued sales of its Alaris infusion pump and for overstating its ...